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Glycine-protected, hypoxic, proximal tubules develop severely compro-
mised energetic function. Glycine-treated, hypoxic, proximal tubules
developed a progressive energetic defect that resulted in failure to restore
ATP levels to greater than 10 to 20% of control values during reoxygen-
ation after 60 minutes of hypoxia despite continued cytoprotection by
glycine. The defect was not corrected by supplementation with exogenous
purines and was not modified by lowering the pH during hypoxia or
reoxygenation. In the continued presence of glycine, the failure to restore
ATP was associated with impaired recovery of structural changes that
developed during hypoxia and, if glycine was withdrawn, lethal membrane
damage occurred. The lesion was significantly ameliorated by the presence
during hypoxia of two agents known to suppress development of the
mitochondrial permeability transition, cyclosporine A and butacaine,
which were most effective when used in combination. The data suggest
that development of the mitochondrial permeability transition in glycine-
protected tubules during hypoxia contributes to continued metabolic and
structural impairment and cell death that occur despite glycine replete
conditions such as exist frequently during in vivo insults and may be a
target for therapeutic maneuvers.
phospholipase activation [8, 91, actin cytoskeletal disruption [4j,
and oxidant damage to cellular lipids and proteins [10]. During
extreme forms of injury such as produced by calcium ionophores
and chemical oxidant insults [2, 8, 10], the plasma membrane
protective effects of glycine can persist well beyond the point at
which intracellular damage would prohibit recovery, even if the
primary insulting agents could be removed. In this report, we
describe a progressive, severe energetic defect which develops
despite glycine cytoprotection during hypoxia of isolated proximal
tubules, severely limits their recovery during reoxygenation, and is
ameliorated by inhibitors of the mitochondrial permeability tran-
sition. This lesion may contribute to continued metabolic and
structural impairment and cell death that occur despite the
presence of glycine during in vivo insults, such as clamp ischemia,
and may be a target for therapeutic maneuvers.
METHODS
Isolation of tubules
Availability of glycine is a major determinant of tubule cell
susceptibility to acute, lethal plasma membrane damage as man-
ifested by the development of increased permeability to vital dyes
and leakage of cytosolic enzymes [1, 2]. The effect of glycine is
robust. Lethal plasma membrane damage that would be maximal
within 15 to 30 minutes in the absence of glycine is completely
prevented for over an hour with full effects requiring 2 to 5 mM
concentrations of the amino acid [2—4]. Since glycine is often
present at cytoprotective concentrations during injury in vivo [5,
6], a complete understanding of the mechanisms of various insults
and their effects on tubule cell structural and functional integrity
requires information about the impact of glycine on the behavior.
Glycine cytoprotection does not require and generally does not
result in amelioration of any of the major pathophysiological
mediators of cell injury, but, rather, allows for maximal expression
of their effects before generalized, nonspecific cell disruption.
Among such events are increases of intracellular calcium [2, 7, 8],
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Proximal tubules were prepared from kidney cortex of female
New Zealand white rabbits (1.5 to 2.0 kg; Oakwood Farms,
Oakwood, MI, USA) by collagenase digestion and centrifugation
on self-forming Percoll gradients [1, 5, 7]. Final tubule pellets
were resuspended at a concentration of 4 to 5.5 mg tubule
protein/mi in ice cold medium gassed with 95% 02/5% CO2. The
medium contained (in mM) 105 NaCI, 2.6 KC1, 25 NaHCO3, 2.4
KH2PO4, 1.25 CaCl2, 1.2 MgCl2, 1.2 Mg504, 5 glucose, 4.5
sodium lactate, I alanine, 10 sodium butyrate, and 3% dialyzed
dextran (Pharmacia, T-40).
Basic procedure for introducing experimental manipulations
As diagrammed in Figure 1, to begin experiments flasks were
warmed to 37°C and prcincuhatcd for 15 minutes under control
oxygenated conditions. Then, the tubules were gently pelleted and
resuspended in fresh medium containing (in mM) 110 NaC1, 2.6
KC1, 25 NaHCO3, 2.4 KH2PO4, 1.25 CaCi2, 1.2 MgCl,, 1.2
Mg504, 5 glucose, 4 sodium lactate, 0.3 alanine, 5.0 sodium
butyrate, 3% dextran, and experimental agents as required and
were regassed with either 95% 02/5% CO2 (time controls) or, to
produce hypoxia, 95% N2/5% CU2, followed by incubation for 15
to 60 minutes prior to sampling for metabolic and structural
parameters. Following this, the remaining tubules were pelleted
and resuspended in fresh 95% 02/5% C02-gassed medium of the
same composition except for replacement of sodium butyrate with
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Hypoxia+reoxygenation (HR)
samples
02/C02 jiM ATP
pH 6.9 or 7.4
0 —5 mM Glycine
2.0 m sodium heptanoate followed by incubation for an addi-
tional 60 minutes, then sampling again for metabolic and struc-
tural parameters. The various manipulations of pH and glycine
concentration (Fig. 1) and additional pharmacologic agents that
were tested are described along with the results of the specific
experiments.
Measurement of lethal membrane damage by lactate
dehydrogenase (LDH) release
LDH activity was measured in the medium before and after the
addition of 0.1% Triton X-100 as described [11].
Determination of cell ATP and total cell K
ATP levels were quantitated by HPLC as previously described
[111 on trichioroacetic acid extracts of the tubules. Medium
supernatarits obtained after removal of the tubules by centrifuga-
tion were also routinely assayed and never contained measurable
amounts of ATP, including those from experiments in which
MgATP was added to the reoxygenation medium. Total cell K4
was measured in tubules separated from their medium by centrif-
ugation through bromododecane (Aldrich, Milwaukee, WI, USA)
by atomic absorption spectroscopy [11]. ATP and electrolyte
values were factored for total cell protein using bovine serum
albumin as the standard [11].
Rhodamine phalloidin staining, immunostaining, and confocal
microscopic observations
Paraformaldehyde-fixed tubules in suspension were examined
after rhodamine phalloidin staining by confocal microscopy as
previously described [4]. Other aliquots of tubule suspensions
were pelleted then fixed in ice-cold paraformaldehyde-lysine-
periodate, cryoprotected, frozen, sectioned, and stained with
either rhodamine phalloidin, or with an anti-fodrin (MAB 1622;
Chernicon, Terrnecula, CA, USA) mouse monoclonal antibody
followed by a lissamine rhodamine-conjugated secondary as pre-
viously described [4, 121.
Reagents
Reagents were from Sigma (St. Louis, MO, USA) unless
otherwise indicated and were of the highest grade commercially
obtainable. ycIosporine A (CsA) was tested as both the inject-
able formulation of Sandimmune (Sandoz, East Hanover, NJ,
USA), which includes Cremophor EL as its vehicle, and as the
pure powder (Calbiochcm, San Diego, CA, USA) freshly solubi-
lized in ethanol each day of use. Agents soluhilized in ethanol
(CsA powder and butacaine) were delivered from 1000>< stock
solutions.
Statistics
All experiments consisted of multiple groups and were analyzed
statistically by analysis of variance for repeated measure or
independent group designs as most appropriate. Individual group
comparisons were then made using the Neuman-Keuls test for
multiple comparisons (SigmaStat; Jandel Scientific, San Rafael,
CA, USA). P < 0.05 was considered to be statistically significant.
The N given represents the number of separate tubule prepara-
tions studied.
RESULTS
Figure 2 summarizes the patterns of LDH release and ATP
levels of tubules subjected to 15, 30, or 60 minutes of hypoxia
followed by 60 minutes of reoxygenation with glycine preseril
during both hypoxia and reoxygenatiori. As expected from our
prior work [8], ATP levels decreased precipitously during hypoxia
to levels less than 5% of those in controls and glycine provided
almost complete protection against LDH release. During reoxy-
genation, protection by glycine against LDH release was main-
tained, however, recovery of ATP levels became progressively
poorer with longer durations of hypoxia, reaching only 10 to 20%
of the control value after 60 minutes of hypoxia plus 60 minutes of
reoxygenation. Each increase in the duration of hypoxia led to a
significant further decrease in the ATP level measured after 60
minutes of reoxygenation.
The failure of ATP recovery could be due to impairment of
ATP production capacity or depletion of the adenine nucleotide
pooi and its precursors. To assess the contribution of purine
availability, the tubules from each flask in the Figure 2 studies
were divided in half at the end of hypoxia and one of the pair
received 250 j.LM MgATP to provide supplemental adenosine for
intracellular ATP synthesis [13] during reoxygenation. The ATP-
supplemented time control preparations had threefold increases
of intracellular ATP levels (Fig. 2) as previously described for this
preparation [13]. Supplementation of reoxygenated, posthypoxic
tubules with ATP also produced significant increases of intracel-
lular ATP after all the durations of hypoxia, but the levels in the
posthypoxic groups remained well under those of unsupple-
mentcd control preparations and progressive decreases of cell
ATP with increasing durations of hypoxia paralleled those seen in
the paired posthypoxic flasks that were not ATP supplemented
(Fig. 2).
End hypoxia (H)
samples
15
021c02
60
NICO2
pH 6.9 or 7.4
2 or 5 mM Glycine Fig. 1. Sequence of experimental maneuvers
and some of the major manipulations tested.
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Fig. 2. Recovery of tubules protected by glycine during hypoxia. (A) LDH
release to the medium (Percent Free LDH) and (B) cell ATP levels were
measured at the end of either 15, 30, or 60 minutes of hypoxia (H, 0) or
after the same durations of hypoxia plus 60 minutes of reoxygenation
without (HR, 7) or with (HR+ATP, 0) the addition of 250 M MgATP
to the medium. The '0' mm' hypoxia values are for control tubules studied
at the corresponding incubation times, that is, 75 minutes for end hypoxia
and 135 minutes for 60 minutes of reoxygenation. Five millimolar glycine
was present during both hypoxia and reoxygenation. The pH was kept at
7.4 during both hypoxia and reoxygenation. Values shown are means SE
from 5 experiments. The SES not shown were either smaller than the
symbols or were less then 10% of the average value and would have
obscured nearby lines. Percent free LDH values do not differ significantly
among the groups. All H ATP values (the bottom curve) are significantly
different from the 0-minute hypoxia time control. All HR values (the
middle curve) are significantly greater than the corresponding H values
and significantly less then the corresponding HR+ATP values (the top
curve). The progressive decreases of ATP levels in the HR and HR+ATP
groups with increasing durations of hypoxia were significant.
Figure 3 summarizes the results of studies to assess whether
lowering the pH during hypoxia to 6.9, a maneuver that is
cytoprotective for the proximal tubules independently of glycine
[4, 9, 14, 15], alters the lesion that develops in the glycine-
protected tubules and to determine the concentrations of glycine
required to maintain cytoprotection during the reoxygenation
period. For these purposes, tubules were subjected to 60 minutes
of hypoxia at either pH 7.4 or 6.9 in the presence of fully
protective concentrations of glycine followed by reoxygenation
with or without supplemental ATP at pH 7.4 and varying glycine
concentrations. Glycine withdrawal during reoxygenation (0 GLY
groups) led to large increases of LDH release. Inclusion of glycine
at 0.25 m during reoxygenation provided detectable protection
in most experiments. Half millimolar glycine was substantially
protective, and 2.0 mrvi glycine was completely protective. Tubules
kept at pH 6.9 during hypoxia did not differ from tubules kept at
pH 7.4 with respect to any of the parameters and the presence of
ATP during reoxygenation did not alter the injury patterns.
Without ATP supplementation during reoxygenation, recovery of
ATP was significantly and equivalently suppressed in all groups.
With supplemental ATP, the glycine-protected groups had signif-
icant, but only modestly better ATP recovery than the unpro-
tected groups, and, as in the Figure 2 studies, their ATP levels
were much lower than those of control tubules with or without
supplemental ATP (Fig. 3). We also tested the effect of maintain-
ing a pH of 6.9 during reoxygenation following hypoxia at pH 6.9.
There was no benefit of this maneuver in the absence of ATP
supplementation and the lower pH during reoxygenation sup-
pressed the increment of intracellular ATP in the tubules that
received exogenous ATP (Table 1).
To further assess the relationship between the impairment of
ATP production during reoxygenation and cellular susceptibility
to lethal membrane damage at that time, tubules were subjected
to either 15, 30, or 60 minutes of hypoxia at either pH 7.4 or pH
6.9 in the presence of protective concentrations of glycine fol-
lowed by 60 minutes of reoxygenation at pH 7.4 in the absence of
glycine without or with 250 /.LM supplemental MgATP (Fig. 4).
There were no differences during hypoxia or reoxygenation in the
behavior of tubules made hypoxic at pH 6.9 as compared to those
that were at pH 7.4. ATP depletion during hypoxia was nearly
maximal, that is, <5% of control, at the first time point sampled,
and the glycine present during hypoxia strongly suppressed LDH
release at all the durations up to 60 minutes. During the subse-
quent reoxygenation in the absence of glycine, tubules subjected
to 15 minutes of glycine-protected hypoxia did not develop
incremental LDH release above that seen in the time control.
ATP levels during reoxygenation after 15 minutes of hypoxia of
both unsupplemented and ATP supplemented preparations were
moderately, but significantly reduced from those of control prep-
arations. During reoxygenation with glycine withdrawal after 30
minutes of glycine-protected hypoxia, tubules developed a mod-
erate but significant degree of incremental LDH release that was
partially ameliorated by ATP supplementation. ATP levels during
reoxygenation of both unsupplemented and ATP-supplemented
groups after 30 minutes of hypoxia were significantly lower than
those of both the time controls and the 15 minutes of hypoxia
groups. However, they still approximated 50% of the correspond-
ing time control values despite the occurrence of lethal membrane
damage at that time. The tubules reoxygenated in the absence of
glycine after 60 minutes of glycine-protected hypoxia developed
extensive LDH release that was not modified by the supplemental
ATP (Fig. 4) as was seen under the same conditions in the Figure
3 studies.
During diverse insults, including hypoxia and chemical anoxia,
the inner mitochondrial membrane sustains a form of damage that
has been termed the "mitochondrial permeability transition"
(MPT) [16, 17]. To begin to assess whether this process could
account for the deficits of hioenergetic function in the glycine-
protected hypoxic tubules, we tested whether tubule recovery was
enhanced by a combination of agents that have been reported to
inhibit development of the MPT. Tubules were subjected to 60
minutes of hypoxia followed by 60 minutes of reoxygenation with
and without ATP either in the presence of glycine alone or with
glycine plus MPT inhibitors (MPTi) throughout. The combination
of MPTi, which consisted of 5 JLM CsA [16—20], 30 p.M butacaine
[16, 19, 21], and 2mM L-carnitine [16, 19], did not affect the extent
of ATP depletion during hypoxia, but substantially improved
recovery of ATP during reoxygenation both with and without
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Fig. 3. Requirement for glycine during
reoxygenation after 60 minutes hypoxia.
Tubules were subjected to 60 minutes of
hypoxia at either pH 6.9 or 7.4. Glycine was
present during hypoxia at 2 mvi in the pH 6.9
groups and at 5 mvi in the pH 7.4 groups.
Tubules were then reoxygenated for 60 minutes
at pH 7.4 in the presence of the indicated
concentrations of glycine (0, 0.25, 0.50, or 2.0
mM) either without () or with (U) 250 rM
MgATP. Values are means SE for 3 to 5
experiments. *significailtly different from
corresponding value for the 0 GLY group at
the same pH. (A) Time control percent free
LDH values were 9.4 0.8 (—ATP) and 9.3
0.8 (+ATP). (B) Time control ATP levels
(nmol/mg protein) were 7.4 0.2 (--ATP) and
22.8 0.8 (+ATP).
Table 1. Effect of pH during reoxygenation on recovery of cell ATP
pH 7.4 pH 6.9
—ATP +ATP -ATP +ATP
Oxygenated 7.8±0.2 22 l.8
—
8.4 03 19.1± l.3
Posthypoxie 0.7 0.04 1.7 008h 0.7 0.2 0.8 0.2'
Values are means SE nmol/mg protein from 3 tubule preparations.
Posthypoxic tubules were subjected to 60 minutes of hypoxia at pH 6.9
in the presence of 2 mvt glycine followed by 60 minutes of reoxygenation
at the indicated pH without (—ATP) or with (+ATP) 250 jsM MgATP
during reoxygenation.
Oxygenated tubules were incubated for 135 minutes. The last 60
minutes were at the indicated pH without (—ATP) or with (+ATP) 250
.rM MgATP. All posthypoxic values significantly less than corresponding
"Oxygenated" values.
"Significantly different from corresponding pH 7.4 group
h Significantly different from corresponding (—ATP) group
supplemental ATP and this improvement in energetics was ac-
companied by much better recovery of cell K (Fig. 5). The MPTi
inhibitors, unlike glycine and unlike their behavior in other cell
Systems [19, 22] did not have primary cytoprotective activities
during hypoxia (Fig. 6).
Figure 7 summarizes the results of studies to determine the
contributions of each of the individual components of the MPTi
combination and the vehicles used for the agents. Equally strong
effects were seen when butacaine and carnitine were combined
with either CsA dissolved in Cremophor vehicle (Fig. 7A) or CsA
dissolved in ethanol vehicle (Fig. 7B). CsA alone in ethanol
vehicle (Fig. 7D) and hutacaine alone (Fig. 7E) each provided
significant benefit, but were significantly less effective than the
combinations. Carnitine alone (Fig. 7F) gave variable results that
failed to reach significance despite the large numbers of samples
studied. Butacaine plus carnitine (Fig. 7C) was not better than
butacaine alone and was slightly, but significantly weaker than the
three agent combinations. Ethanol alone as used to deliver CsA
and butacaine was entirely without effect. In additional studies of
lower concentrations of CsA (not shown), 0.1 1M was without
effect and 0.5 fLM was marginally protective.
Presence of the MPTi during hypoxia was sufficient to confer
their full benefit (Fig. 8). Addition during reoxygenation alone
had no effect (Fig. 8). They also did not appreciably affect the rate
of ATP depletion during hypoxia (Table 2).
Figure 9 summarizes the changes in staining patterns for two
major cytoskeletal proteins during the 60 minutes of hypoxia and
recovery maneuvers. In controls (panels a and d of the 'F-ACTIN
(suspension)' and 'F-ACTIN' sets of pictures), rhodamine phal-
loidin staining of F-actin was concentrated in the microvilli, which
were uniform in appearance and well preserved, and at the basal
surface, as previously described [8, 12]. At the end of 60 minutes
of hypoxia, virtually all glycine alone and glycine+MPTi tubules
showed similar alterations of rhodamine phalloidin staining for
actin with pronounced loss of staining along the basal surface and
shortening and irregularity of staining of apical microvilli (Fig. 9
panels b and c of each set). After the 60-minute reoxygenation
period, the tubules treated with glycine alone had a heterogenous
picture with the majority showing either no or very weak recovery
(Fig. 9 panel e of each set). Only occasional tubules showed
stronger recovery of staining patterns that approached those of
controls. In contrast, the dominant pattern in the glycine+MPTi-
treated samples was of substantial or complete recovery (Fig. 9
panel f), although 20 to 30% of tubules had little or no recovery
as in the absence of the MPTi. Figure 9 also shows the results of
immunostaining for fodrin. In control tubule preparations (Fig.
9 a, d, FODRIN), fodrin staining was present along the basolat-
eral membrane and subapically as previously described [121.
During 60 minutes of hypoxia, the hasolateral fodrin staining
became weaker and less distinct and, in some cells, there was
generalized intracellular redistribution. Similar changes were seen
with and without the MPTi (Fig. 9 b, c, FODRIN). During (i()
minutes of reoxygenation, most tubules without the MPTi re-
tained the same appearance as at the end of hypoxia (Fig. 9e,
FODRIN), while most tubules with the MPTi substantially recov-
ered a fodrin distribution similar to that of controls (Fig. 9f,
FODRI N).
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DISCUSSION
Low millimolar concentrations of glycine greatly enhance resis-
tance of freshly isolated proximal tubules and a variety of other
cell types to lethal plasma membrane damage [1—5, 7—12, 15,
23—28]. This effect is neither mediated by nor necessarily associ-
ated with preservation of cellular ATP [2, 8, 11, 12, 24], mainte-
nance of intracellular glutathione [11], amelioration of increases
of cytosolic free Ca2 [2, 7—9, l2, 15, 23, 24], promotion of
intracellular acidification [15], prevention of phospholipid hydro-
lysis [8, 9, 231, modification of ATP depletion or Ca2-induced
alterations of the actin cytoskeleton [4, 121, or inhibition of lipid
peroxidation [10, 24]. Cytoprotection may result from suppression
of the development of a pathological plasma membrane pore
involving proteins that can he stabilized by weak interactions with
certain natural and pharmacologic modulators of Cl channels
[25—27].
Recent studies using maneuvers designed to elicit extreme
forms of cellular damage and, thereby, rigorously test their
involvement in glycine cytoprotection have shown that the effect
of the amino acid to prevent pathological increases of plasma
membrane permeability can be maintained under conditions
where cells are otherwise metabolically and structurally disrupted
well beyond the point at which they could be considered to be still
viable, that is, capable of recovering normal metabolic, repair, and
proliferative functions after removal of the insult. Probably the
best, although not the only, illustration of this is the behavior of
both freshly isolated and cultured tubule cells subjected to
treatment with combinations of metabolic inhibitors and iono-
TC NFA GLY GLY GLY
6.9 6.9
GsA
BUT
CARN
Fig. 6. Effects of mitochondrial permeability transition inhibitors on
injury during hypoxia in the absence of glycine. Tubules were subjected to
60 minutes of hypoxia in the presence of either no further experimental
additions (NFA), 2 ms glycine, 2 mM glycine + lowering of medium pH
to 6.9 (GLY,6.9), 'GLY,6.9' medium also containing 5 M CsA, 30 M
butacaine (BUT), and 2 mrvt L-carnitine (CARN), medium modified only
by the addition of CsA+BUT+CARN, and medium modified by addition
of CsA alone. CsA, BUT, and CARN were also present during the
15-minute preincubation period before hypoxia. CsA was in Cremophor
vehicle. TC is time control. Values are means se of experiments on 4
separate tubule preparations. *p < 0.05 versus NFA group.
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Fig. 5. Effects of mitochondrial permeability transition inhibitors on recovery of glycine-protected tubules. Tubules were subjected to 60 minutes of
hypoxia (H, LI), 60 minutes of hypoxia + 60 minutes of reoxygenation without (HR, ) or with (HR+ATP, ) 250 tLM ATP during reoxygenation or
incubation under oxygenated conditions (Control) for the corresponding durations; 250 j.rM ATP was added during reoxygenation to the HR+ATP
groups. Groups designated 'GLY' were incubated at pH 6.9 with 2 mrvi glycine during hypoxia and at pH 7.4 with 2 mM glycine during reoxygenation.
Groups designated 'GLY,MPTi' were treated like the 'GLY' groups except they received a combination of MPT inhibitors (MPTi) for 15 minutes prior
to hypoxia, during the 60-minute hypoxic period, and during the 60-minute reoxygenation period. The MPTi used were: 5 j.M CsA in Cremophor vehicle,
30 !LM butacaine, and 2 mti L-carnitine. Values are means SE of experiments on 4 separate tubule preparations. *significantly different from
corresponding GLY group. The off scale ATP value for the Control+ATP group was 21.7 1.7 nmol/mg protein.
100.0
r
a-C0o
0
a-C0o
0
I0
-J
ci)
U-
75.0
50.0
25.0
0.0
* *
CsA CsA
BUT
CARN
146 Weinberg et al: Impaired energetics during glycine cytoprotection
phores in Ca2-replete media in the presence of glycine. Under
these conditions, massive reorganization of all cellular mem-
branes [81, phospholipid hydrolysis [8, 9, 23], and actin depoly-
merization [4, 12], occur in cells whose plasma membranes
continue for prolonged periods to exclude vital dyes and retain
cytosolic proteins.
During 30 to 60 minutes of hypoxia in the presence of glycine,
proximal tubule cells develop swelling of apical microvilli, frag-
mentation of their actin cores, losses of basal membrane-associ-
ated actin, and alterations in the normal basolateral immunostain-
ing pattern for fodrin, but overall, remain remarkably intact
ultrastructurally [3, 9, 12] (Fig. 9). The original description of
glycine cytoprotection was based on its effect to greatly improve
recovery of cellular metabolic parameters, that is, respiration,
ATP, and K' levels, at the end of 30 minutes of hypoxia plus 60
minutes of reoxygenation as compared to tubules that were
hypoxic in the absence of glycine [1]. However, respiratory rates
and ATP in the glycine-protected tubules were not quite fully
restored to control levels [11. The present studies indicate that this
was due to a progressive deficit in ATP synthetic capacity which
develops in the glycine-protected tubules, becomes sufficiently
severe when durations of hypoxia exceed 30 minutes to limit
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Fig. 7. Effects of MPTi individually and in combination on recovery of cell ATP in glycine-protected tubules. Tubules were subjected to 60 minutes of
hypoxia in the presence of 2.0 m'vi glycine at pH 6.9 followed by 60 minutes of reoxygenation in the presence of 2.0 mvt glycine at pH 7.4 without (—ATP)
or with 250 M MgATP (+ATP) and either no further experimental additions () or the indicated MPTi (•), which were present for 15 minutes prior
to hypoxia, during hypoxia, and during reoxygenation. Values in each panel are means SE of sets of fully paired experiments. *Signiflcantly different
from the paired no further experimental addition samples. All +ATP groups were significantly different from corresponding —ATP groups. The MPTi
tested and numbers of experiment for each were: (A) 5 j.LM CsA in Cremophor vehicle, 30 /LM butacaine, and 2 mtvt L-carnitine (CsAcr,BUT,CARN),
N = 15; (B) 5 M CsA in ethanol vehicle, 30 rM butacaine, and 2 mrvi L-carnitine (CsAe,BUT,CARN), N = 5; (C) 30 /.LM butacaine and 2 mai L-carnitine(BUT,CARN), N = 14; (D) 5 jLM CsA in ethanol vehicle (CsAe), N = 4; (E) 30 j.rM butacaine (BUTACAINE), N = 7; (F) 2 mM L-carnitinc(CARNITINE), N = 11. Paired control ATP values (not shown) for the various groups ranged from 7 to 7.5 nmol/mg protein in the absence of ATP
and 22 to 24 nmol/mg protein the presence of ATP. Ethanol (0.18%) as used to deliver the butacaine and CsAe (EtOH) had no effect (N = 6) on
recovery of cell ATP either without (—ethanol 0.70 0.11, +ethanol 0.70 0.1) or with MgATP (—ethanol 1.97 0.31, +ethanol 2.01 0.26).
CsAe,BUT,CARN had no effect (N = 4) on cell ATP (nmol/mg protein) of oxygenated tubules either without (—CsAe,BUT,CARN 6.80 0.75,
+CsAe,BUT,CARN 7.70 0.20) or with MgATP (—CsAe,BUT,CARN 21.24 2.3, +CsAe,BUT,CARN 19.38 1.80).
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0
Fig. 8. Timing of beneficial MPTi effect on recovery of cell ATP in
glycine-protected tubules. Tubules were subjected to 60 minutes of
hypoxia in the presence of 2.0 mM glycine at pH 6.9 + 60 minutes of
reoxygenation in the presence of 2.0 mrvi glycine at pH 7.4 without () or
with 250 tLNl ATP (U) and either no further experimental additions (Gly
only) or MPTi during preincubation+hypoxia+reoxygenation (H+R),
preincubation+hypoxia alone (H only) or reoxygenation alone (R only).
The MPTi used were CsA in Cremophor vehicle +30 jtM butacaine+2 mM
L-carnitine. Values are means SE of three fully paired experiments
including every condition. *signiflcantly different from the paired no
further experimental addition samples.
functional and structural recovery of tubules kept in the presence
of glycine, and leads to lethal membrane damage if glycine is
withdrawn.
Proximal tubule ATP production, particularly in the SI and S2
segments that predominate in the isolated tubule preparations,
derives virtually entirely from mitochondrial oxidative phosphor-
ylation [28]. Extracellular ATP is catabolized by the isolated
tubules to adenosine which can be transported into the tubule
cells and readily rephosphorylated resulting in 2.5- to threefold
increases of cell ATP under control oxygenated conditions [13]
(Fig. 2). Similar behavior is seen in the isolated perfused kidney
[29] and has been shown to account for the effects of systemic
MgATP to increase renal cortex ATP levels postischemia in vivo
[30]. Although posthypoxic tubule cell ATP levels were consis-
tently increased by provision of exogenous ATP in the present
studies, they decreased roughly in parallel with the levels of the
unsupplemented tubules as duration of hypoxia was increased,
indicating that the impaired recovery of ATP resulted from a
limitation of phosphorylation capacity rather than of purine
nucleotide precursor availability. MgATP infusion in vivo is
beneficial in clamp models of acute renal failure in the rat [31],
although toxic effects have been described in the isolated perfused
kidney [32], and, in previous studies that did not include glycine,
we were unable to show protection by exogenous ATP against
lethal membrane damage that accompanied its actions to increase
intracellular ATP [33]. The glycine withdrawal studies summa-
rized in Figure 4 provide evidence for a beneficial effect of ATP of
lethal membrane damage, but it was limited to tubules subjected
to 30 minutes of hypoxia and was relatively small in magnitude.
On the other hand, we did not detect any toxic effect of the
Table 2. ATP levels during hypoxia with and without MPTi
-MPTi +MPTi
15 mm Hypoxia 0.22 0.02 0.26 0.03
30 mm Hypoxia 0.20 0.02 0.16 0.02
60 mm Hypoxia 0.16 0.01 0.16 0.02
Values are means SE nmol/mg protein from 7 tubule preparations.
Tubules were subjected to hypoxia for the indicated durations at pH 6.9
in the presence of 2 msi glycine either without (—MPT1) or with (+MPTi)
CsA in Creniophor vehicle plus butacaine plus carnitine. All values are
significantly less than the control ATP level of 6.2 0.2 nmol/mg protein.
None of the —MPTi and +MPTi values at corresponding durations of
hypoxia are significantly different.
exogenous ATP in the oxygenated time control tubules treated
with it.
The decreases of ATP recovery capacity with increasing dura-
tions of glycine-protected hypoxia could reflect functional deficits
that occur in all tubule cells relatively uniformly or could be due
to increases in the proportion of severely affected cells that have
catastrophically lost virtually all phosphorylation capability, while
the remaining cells remain metabolically competent. Several of
the observations strongly favor the presence of subpopulations of
cells with profound loss of bioenergetic function. When glycine is
withdrawn during severe ATP depletion, its cytoprotective effects
disappear virtually immediately ([34] and Venkatachalam and
Weinberg, unpublished observations). Glycine withdrawal during
reoxygenation in the present studies led to LDH release that
correlated with the extent of ATP depletion seen under the same
conditions in the continued presence of glycine and had essen-
tially the same sensitivity to glycine, that is, a 0.25 m threshold
glycine concentration for protection, as seen in rabbit tubules
during hypoxia [31. Also, as shown in Figure 4, after the 30 minute
duration of hypoxia, excess LDH release as compared to controls
was seen in the ATP supplemented tubules that had glycine
withdrawn even though the overall ATP levels measured in those
suspensions were 75% higher than the levels of time controls ('0
mm hypoxia' groups in Fig. 4) that were not ATP supplemented.
This can only be explained by the presence of a subpopulation of
cells with severely suppressed ATP that have developed lethal
membrane damage in the absence of glycine while the remaining
tubule cells have the supranormal ATP levels produced by the
supplementation with MgATP. The heterogeneity of structural
recovery during reoxygenation is also consistent with this inter-
pretation.
It has been recognized for some time that a variety of insults
can produce an increase of the permeability of the inner mito-
chondrial membrane, which necessarily compromises the low
permeability to ions necessary for energy conservation [16, 17, 20,
35, 36]. The process, now frequently termed the mitochondrial
permeability transition. MPT, is characterized by loss of inorganic
and small organic matrix solutes including proteins, and mito-
chondrial swelling. Considerable evidence has emerged during the
past several years that the MPT results from reversible opening of
proteinaeeous pore approximating 3 nm in diameter [16, 17, 20,
35, 36]. The state of the pore is normally regulated by matrix
divalent cations, membrane potential, surface potential, matrix
pH, and matrix ADP [16, 17, 20, 35, 36]. Opening of the pore can
be prevented and reversed by the immunosuppressive agent, CsA
[16—18, 20], via inhibition by CsA of the binding of a unique
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mitochondrial matrix cyclophilin with the inner mitochondrial
membrane 137—391 "Inducing factors" (fully detailed in [161 and
further reviewed in [17, 201) that promote development of the
MPT include Ca2, phosphate, de-energization, oxidizing condi-
tions, a variety of lipid breakdown products, and the adenine
nucleotide translocase inhibitor, atractyloside. Conditions or
agents other than CsA that inhibit the MPT include decreased
pH, ADP, Mg2, chelation of free Ca2, antioxidants, reduction
of pyridine nucleotides, carnitine, local anesthetics, bongkrekic
acid, and several calmodulin and Ca2 channel antagonists [16,
17, 201.
Many of the "inducing factors" and inhibitory conditions that
are normally expressed in cells (that is, intracellular Ca2, phos-
phate, reactive oxygen metabolites, lipid metabolites, pH, Mg2
and ADP) undergo major changes during ischemia and postisch-
emic reoxygenation [28], which could variously serve to promote
or retard development of the MPT, and there is evidence for
involvement of the MPT in mitochondrial damage during patho-
logical states [16, 19, 22, 40—421. In the present studies, lowering
the pH to 6.9 during hypoxia or during hypoxia+reoxygenation
did not influence tubule behavior, but MPT inhibitors did. We
initially used a combination of MPT inhibitors because of the
multiplicity of pathways interacting to produce the MPT and well
documented observations that transient effects of single agents to
suppress the MPT can he markedly prolonged by targeting
additional components of the process [41, 43]. The CsA, buta-
caine, and carnitirie combination potentially targets several con-
tributory factors to the MPT: (I) CsA inhibits the interaction of
cyclophilin with the pore protein(s) that favor the open state [16,
17, 20, 37—39]; (2) butacaine alters membrane surface potential
and/or antagonizes interaction of matrix Ca2 with the pore
protein or with phospholipases whose actions promote pore
opening [17, 19—21, 43, I; and (3) carnitine lowers mitochon-
drial matrix levels of pore-activating long ehain fatty acids that
accumulate as a result of suppressed electron transport and
phospholipase activity [16, 19, 44]. Our data indicate considerable
efficacy of the MPTi, but are consistent with the occurrence of
complex interactions in that CsA and butacaine were both bene-
ficial when used individually, and the combination of butacaine
plus CsA plus carnitine was better. Carnitine did not appear to
have an effect alone or in combination with butacaine.
There are a number of reports that CsA and other inhibitors of
the MPT can have cytoprotective effects during ATP depletion
and oxidant-induced insults [19, 22, 42, 45, 46j. Although this was
not the case for the hypoxic tubules (Fig. 6), MPTi had to he
introduced during hypoxia for the improvement in ATP during
reoxygenation to occur. Addition during reoxygenation was with-
out benefit for the tubules. This suggests that the lesion in the
tubules develops during hypoxia and must be prevented at that
time or occurs immediately upon reoxygenation and simultaneous
introduction of the MPTi is not sufficient, hut more work will be
necessary to clarify this behavior. Conditions present during
reoxygenation, such as increased reactive oxygen metabolite gen-
eration and mitochondrial Ca2 uptake resulting from resump-
tion of electron transport, could result in worsening of the MPT or
in its de novo development at that time. We have, thus far, not
found any benefit of antioxidants or manipulating Ca2 availabil-
ity (manuscript in preparation), but further studies of these issues
and the timing of the insult will be required to fully understand
the mechanism.
The fluorescence microscopy studies of F-actin and fodrin in
the tubules demonstrate that the improved metabolic recovery
with MPTi is accompanied by enhanced restoration of the normal
cytoskeletal architecture that is critical for functional integrity of
the epithelium [47J. Hypoxia-associated alterations of F-actin in
both of its major visible sites, the apical microvilli and along the
basal membrane, completely reversed in a majority of cells when
ATP recovery was improved by the MPTi and this was accompa-
nied by parallel changes of fodrin. These observations also suggest
that this system may be of considerable value for studying
mechanisms of recovery from ATP depletion-induced cytoskeletal
alterations in fully differentiated proximal tubule cells.
Intracellular glycine concentrations in the kidney range from 4
to > 30 m depending on the species and, because the extracel-
lular space in vivo is small relative to the intracellular space,
leakage as a result of loss of ATP-dependent concentrative
mechanisms during ischemia still leaves m concentrations in
both cells and the extracellular space [5, 6]. Freshly isolated
tubules are depleted of glycine during their preparation in glycine-
free solutions [51. Cultured cells lose endogenous glycine to the
relatively large extracellular space during ATP depletion states
because of the failure of ATP-dependent, concentrative transport
mechanisms [23j. Thus, the resistance to injury conferred by
glycine in vitro reflects restoration of a factor usually available in
vivo. The present studies suggest that development of the mito-
chondrial permeability transition despite glycine cytoprotection of
hypoxic tubules is a major limiting factor for their recovery that is
a potential target for pharmacologic manipulation, and provide a
mechanism for injury that occurs under glycine replete conditions
such as clamp ischemia in vivo. They also indicate the importance
of assessing ATP levels for the interpretation of tubule behavior
during conditions such as reoxygenation in the presence of
cytoprotective maneuvers, where metabolic competence of cells
and recovery processes dependent on it may be highly compro-
mised despite suppression of plasma membrane damage.
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